These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25395585)

  • 21. Duchenne muscular dystrophy in a female child.
    Joshi S
    Indian Pediatr; 2002 Jan; 39(1):98. PubMed ID: 11805363
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy.
    Wein N; Alfano L; Flanigan KM
    Pediatr Clin North Am; 2015 Jun; 62(3):723-42. PubMed ID: 26022172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A bedside measure of body composition in Duchenne muscular dystrophy.
    Elliott SA; Davidson ZE; Davies PS; Truby H
    Pediatr Neurol; 2015 Jan; 52(1):82-7. PubMed ID: 25301226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaching therapies for boys with Duchenne muscular dystrophy. Parent Project Muscular Dystrophy. Annual conference in Cincinnati/Ohio, 13-16 July 2006.
    Scheuerbrandt G
    Acta Myol; 2006 Oct; 25(2):77-97. PubMed ID: 18593009
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosis and management of Duchenne muscular dystrophy.
    Baxter P
    Dev Med Child Neurol; 2010 Apr; 52(4):313. PubMed ID: 20412247
    [No Abstract]   [Full Text] [Related]  

  • 26. Wolff-Parkinson-White syndrome in Duchenne muscular dystrophy.
    Fayssoil A; Amara W; Annane D; Orlikowski D
    Int J Cardiol; 2013 Aug; 167(3):e53-4. PubMed ID: 23642616
    [No Abstract]   [Full Text] [Related]  

  • 27. [Early diagnosis of Duchenne muscular dystrophy by means of non selective neonatal screening].
    Martín Fernandez-Mayoralas D; San Antonio-Arce V; Campos-Castelló J
    Rev Neurol; 2002 Sep 16-30; 35(6):595-6. PubMed ID: 12389180
    [No Abstract]   [Full Text] [Related]  

  • 28. Composite biomarkers for assessing Duchenne muscular dystrophy: an initial assessment.
    Shklyar I; Pasternak A; Kapur K; Darras BT; Rutkove SB
    Pediatr Neurol; 2015 Feb; 52(2):202-5. PubMed ID: 25447928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duchenne muscular dystrophy: a 30-year population-based incidence study.
    Dooley J; Gordon KE; Dodds L; MacSween J
    Clin Pediatr (Phila); 2010 Feb; 49(2):177-9. PubMed ID: 20080524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can outcomes in Duchenne muscular dystrophy be improved by public reporting of data?
    Peay HL; Scully MA; Cwik VA; Ciafaloni E; Griggs RC
    Neurology; 2013 Nov; 81(20):1802. PubMed ID: 24218315
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular diagnosis of Duchenne muscular dystrophy.
    Nallamilli BR; Ankala A; Hegde M
    Curr Protoc Hum Genet; 2014 Oct; 83():9.25.1-29. PubMed ID: 25271841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precordial R wave height does not correlate with echocardiographic findings in boys with Duchenne muscular dystrophy.
    Thrush PT; Edward N; Flanigan KM; Mendell JR; Allen HD
    Congenit Heart Dis; 2013; 8(6):561-7. PubMed ID: 23510265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duchenne and Becker muscular dystrophies.
    Flanigan KM
    Neurol Clin; 2014 Aug; 32(3):671-88, viii. PubMed ID: 25037084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis and natural history of Duchenne muscular dystrophy].
    Desguerre I; Laugel V
    Arch Pediatr; 2015 Dec; 22(12 Suppl 1):12S24-30. PubMed ID: 26773582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.
    Spurney CF
    Muscle Nerve; 2011 Jul; 44(1):8-19. PubMed ID: 21674516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early diagnosis of Duchenne muscular dystrophy with high level of transaminases.
    Kurul S; Ulgenalp A; Dirik E; Ercal D
    Indian Pediatr; 2002 Feb; 39(2):210-1. PubMed ID: 11867860
    [No Abstract]   [Full Text] [Related]  

  • 38. Carrier detection and prenatal diagnosis in Duchenne/Becker muscular dystrophy.
    Panigrahi I; Mittal B
    Indian Pediatr; 2001 Jun; 38(6):631-9. PubMed ID: 11418728
    [No Abstract]   [Full Text] [Related]  

  • 39. Can urinary titin be used for predicting Duchenne muscular dystrophy?
    Bai SM; Guo XX
    Clin Chim Acta; 2019 Mar; 490():161. PubMed ID: 30391395
    [No Abstract]   [Full Text] [Related]  

  • 40. [Duchenne muscular dystrophy: current aspects and perspectives on treatment].
    López-Hernández LB; Vázquez-Cárdenas NA; Luna-Padrón E
    Rev Neurol; 2009 Oct 1-15; 49(7):369-75. PubMed ID: 19774532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.